Pfizer Won't Face Retrial In Premarin Breast Cancer Suit

Law360, New York (October 25, 2012, 8:02 PM EDT) -- An Arkansas federal judge refused Wednesday to grant a new trial to a woman who claimed Premarin and other menopause hormone therapy drugs by Pfizer Inc. units Wyeth Pharmaceuticals Inc. and Pharmacia & Upjohn Inc. gave her breast cancer.

U.S. District Judge Billy Roy Wilson upheld a jury's August verdict for Pfizer, rejecting Sondra Welch's claims over juror misconduct and that certain information that a bailiff had shared with the jurors about previous Pfizer hormone therapy drug trials had been prejudicial.

“We are pleased that the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Welch v. Wyeth et al


Case Number

4:06-cv-00299

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Billy Roy Wilson

Date Filed

March 8, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.